Research location
Avranches
France
Advertisement
Research activity in Avranches
FranceCureCurrent currently publishes aggregate city-level research activity for this location: 10 trials and 10 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Avranches
10 linked trials · page 1 of 1Efficacy and Safety of a Releasable Intraluminal Suture Technique to Reduce Hypotony Following Glaucoma Surgery Using the Preserflo DeviceNCT07531199 · 2026-09-17 · 1 site observation
RECRUITING
Efficacy and Safety of Tran Cannula in Combined Pseudoexfoliative Glaucoma and Cataract Surgery Compared With Augmented Ocular IrrigationNCT06979752 · 2025-06-04 · 1 site observation
RECRUITING
Efficacy and Safety of the ELIOS Laser in Combined Cataract and Glaucoma SurgeryNCT06760169 · 2025-01-05 · 1 site observation
RECRUITING
Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract SurgeryNCT06246136 · 2023-12-05 · 1 site observation
RECRUITING
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood SpotNCT05390424 · 2022-12-02 · 1 site observation
RECRUITING
Efficacy and Safety of Minimally Invasive Micro-Sclerostomy (MIMS) in Glaucoma SurgeryNCT06213805 · 2024-01-15 · 1 site observation
COMPLETED
Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular HypertensionNCT02507687 · 2015-08-27 · 1 site observation
COMPLETED
A Phase III Study for Patients With Metastatic Hormone-naïve Prostate CancerNCT01957436 · 2013-11-13 · 1 site observation
ACTIVE_NOT_RECRUITING
National Survey on HypertensionNCT00804167 · 2008-12-01 · 1 site observation
COMPLETED
Tysabri Observational ProgramNCT00493298 · 2007-06-29 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.